369P - Observed survival following treatment with
Post# of 151465
(Total Views: 401)
Posted On: 03/30/2025 10:29:47 AM
369P - Observed survival following treatment with Leronlimab in patients with metastatic Triple-Negative Breast Cancer (mTNBC). (ID 1079)
Lecture Time
12:00 - 12:00
Speakers
Richard G. Pestell (Philadelphia, United States of America)
https://cslide.ctimeetingtech.com/breast2025/...session/52
Will the abstract show up on here?
Lecture Time
12:00 - 12:00
Speakers
Richard G. Pestell (Philadelphia, United States of America)
https://cslide.ctimeetingtech.com/breast2025/...session/52
Will the abstract show up on here?
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼